These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 701485)

  • 1. Inhibition of erythrocyte sickling in vitro by pyridoxal.
    Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
    J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheological assessment of antisickling effects of pyridoxine and pyridoxal.
    Kuranstin-Mills J; Lessin LS
    Blood Cells; 1982; 8(2):315-28. PubMed ID: 7159755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.
    Nigen AM; Manning JM
    J Clin Invest; 1978 Jan; 61(1):11-9. PubMed ID: 618907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of erythrocyte sickling in vitro by DL-glyceraldehyde.
    Nigen AM; Manning JM
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):367-71. PubMed ID: 264689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of sickle cell anemia with induced hyponatremia.
    Rosa RM; Bierer BE; Bunn HF; Epstein FH
    Blood Cells; 1982; 8(2):329-35. PubMed ID: 7159756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sickle cell anemia and the affinity of the blood for oxygen].
    Pocidalo JJ; Sinet M
    C R Seances Soc Biol Fil; 1979; 173(2):303-13. PubMed ID: 159755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridoxal phosphate as an antisickling agent in vitro.
    Kark JA; Tarassoff PG; Bongiovanni R
    J Clin Invest; 1983 May; 71(5):1224-9. PubMed ID: 6853710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.
    Green MA; Noguchi CT; Keidan AJ; Marwah SS; Stuart J
    J Clin Invest; 1988 Jun; 81(6):1669-74. PubMed ID: 3384944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity.
    Noguchi CT; Torchia DA; Schechter AN
    J Clin Invest; 1983 Sep; 72(3):846-52. PubMed ID: 6886006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of intracellular hemoglobin with pyridoxal and pyridoxal 5'-phosphate.
    Kark JA; Bongiovanni R; Hicks CU; Tarassoff PG; Hannah JS; Yoshida GY
    Blood Cells; 1982; 8(2):299-314. PubMed ID: 7159754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of blood from patients with sickle cell disease to air changes the morphological, oxygen-binding, and sickling properties of sickled erythrocytes.
    Obata K; Mattiello J; Asakura K; Ohene-Frempong K; Asakura T
    Am J Hematol; 2006 Jan; 81(1):26-35. PubMed ID: 16369974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling.
    Abraham EC; Stallings M; Abraham A; Garbutt GJ
    Biochim Biophys Acta; 1982 Jul; 705(1):76-81. PubMed ID: 7115734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5'-deoxypyridoxal as a potential anti-sickling agent.
    Benesch R; Benesch RE; Edalji R; Suzuki T
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1721-3. PubMed ID: 266212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
    Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.